Cargando…
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver diseases (CLDs) are not well understood. For a metabolic factor to be identified as a risk factor for HCC in patients w...
Autores principales: | Shin, Hwang Sik, Jun, Baek Gyu, Yi, Sang-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597232/ https://www.ncbi.nlm.nih.gov/pubmed/35934813 http://dx.doi.org/10.3350/cmh.2021.0383 |
Ejemplares similares
-
The Association between Obesity Phenotypes and Early Renal Function Decline in Adults without Hypertension, Dyslipidemia, and Diabetes
por: Choi, Jung In, et al.
Publicado: (2019) -
Obesity, Dyslipidemia, Diabetes, and Vitamin D Levels
por: Moya, Elena A Amoroso, et al.
Publicado: (2021) -
Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children
por: Deeb, Asma, et al.
Publicado: (2018) -
The Pattern of Dyslipidemia in Chronic Liver Disease Patients
por: Farooque, Umar, et al.
Publicado: (2021) -
Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)